Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0183-2022Class I

Ellume COVID-19 Home Test

Ellume Ltd / initiated 2021-10-01 / Open, Classified / root cause: manufacturing process

ELLUME LTD began a recall of Ellume COVID-19 Home Test on . FDA classified it as Class I and gives the reason as "Due to a higher rate of false positive test results". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0183-2022
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Ellume Ltd
Product
Ellume COVID-19 Home Test
Product code
QKP Coronavirus Antigen Detection Test System.
Reason for recall
Due to a higher rate of false positive test results.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On 10/01/2021, the Recalling Firm communicated an "URGENT: MEDICAL DEVICE RECALL" Notification letter via email to its: -Distributors/retailer -Customers/users that include customers that have used the products within 2 weeks and beyond 2 weeks. The communications informed customer that the Recalling Firm has received a number of complaints stating false positive test results for it COVID-19 Home Test kits. If consumers have used an affected product before 09/17/2021 and tested positive are advised that their test results could have been incorrect. For Distributor and Retailers, they are instructed to: 1. Remove affected products from their shelves and cease sales and distibution. 2. Quarantine the affected products immediately 3. Contact the Recalling Firm's sales representatives for further instructions on the disposal of affected product. 4.Complete and return the attached Acknowledgement Form acknowledging their receipt of the Recall Notification and confirming that they have returned or destroyed the affected product. Return Acknowledgement Form to the Recalling Firm at [email protected] 5. If the affected products have been further distributed, notify any accounts or additional locations and share the Recall Notification with them 6. Immediately notify the Recalling Firm of any accounts or additional locations that may have received the affected product. For Consumers that have used the affected products: Users that have used the affected products within the last two weeks are being informed and instructed to: 1. If they have received a positive test result, this result may be incorrect and they should contact a healthcare professional immediately and notify them of this recall and ask to obtain a confirmatory test (i.e., molecular or RT-PCR). 2. If they have already had a confirmatory test that confirms they DO have COVID-19, disregard this letter and follow their healthcare professional's advice and CDC guidance on self-isolation,
Quantity in commerce
427,994 kits
Distribution
U.S.: MN, NY, PA, RI, UT, WA. O.U.S.: Not provided
Product codes and lots
Catalogue number I-SRS-C-01 Master Lot Numbers: 21047-4; 21047-5; 21089-1; 21117-1; PF06Z-H; 21099-1; 21124-1; 21125-1; PF03X-H; PF057-H; PF05W-H; PF069-H; PF06E-H; PF06N-H; PF06Z-H; PG080-H; PG08H-H; PH08X-H;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0183-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0183-2022Class IOngoingVoluntary: Firm initiated